Vimarsana
Biggest News Aggregation in the World

Priority Pathogen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Priority Pathogen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Priority Pathogen Today - Breaking & Trending Today

Recce Pharmaceuticals Completes Stage 1 Data Analysis of - Vimarsana News

Recce Pharmaceuticals Completes Stage 1 Data Analysis of

Patients with bacterial infections successfully treated with RECCE® 327 (R327)Deadly bacterial pathogens treated with R327 include those identified by the...

Recce Pharmaceuticals Provides Positive Update on Patients Treated with RECCE® 327 Under "Special Access Scheme" - Vimarsana News

Recce Pharmaceuticals Provides Positive Update on Patients Treated with RECCE® 327 Under "Special Access Scheme"

Figure 1 Patient Case Study Example A Figure 2 Patient Case Study Example B Figure 3 Clearing in a lawn of Escherichia coli (E. coli) on solid LB-agar media. Table 1 Table 1 RECCE® 327 as a gel formulation (R327G) demonstrated a positive clinical response in the treatment of multiple antibiotic-resistant infections under Therapeutic Goods Administration (TGA) Special Access Scheme (SAS) Category AIn an ex-vivo burn wound study, R327G showed a 4 to 5-log reduction (>99.99%) against Methicillin-re

Source: yahoo.com
INOVIO Reports Positive Phase 1b Results for INO-4201 as an Ebola Booster for rVSV-ZEBOV (Ervebo®) - Vimarsana News

INOVIO Reports Positive Phase 1b Results for INO-4201 as an Ebola Booster for rVSV-ZEBOV (Ervebo®)

/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...

"A strong pipeline of vaccines is under development with nearly 8 different vaccines targeting the critical priority pathogens of AMR" - Vimarsana News

"A strong pipeline of vaccines is under development with nearly 8 different vaccines targeting the critical priority pathogens of AMR"

Dr Renu Swarup, Former Secretary to the Government of India, Department of Biotechnology (DBT), Ministry of Science & Technology, was recently appointed as a member of the International Centre for Antimicrobial Resistance Solutions (ICARS) Board of Directors. Dr Renu Swarup, with almost three decades in the DBT, brings a wealth of knowledge and experience to support ICARS in its mission to combat antimicrobial resistance (AMR) in low- and middle-income countries (LMICs). She has played a key role in formulating India’s Biotechnology Vision and Strategy and is credited with setting up I...

What Is Marburg Virus? Ghana Confirms Its First Outbreak Of Highly Infectious Virus - Vimarsana News

What Is Marburg Virus? Ghana Confirms Its First Outbreak Of Highly Infectious Virus

What is Marburg Virus? The Marburg virus (MARV), a virus that causes viral hemorrhagic fever in humans and primates, causes Marburg virus illness. It is claimed that the virus is very deadly.